Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219829 · ClinicalTrials.gov registry record
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 5
- Enrollment target
NCT01219829: Completed study, sponsored by Columbia University.
NCT01219829 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01219829 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.
Primary Outcome
Distinctive histological features of PanIN within surgical specimens of our two study groups will be assessed by pathologists.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-03-18 |
| Est. Completion | 2021-04-27 |
What the finished NCT01219829 record still lists
NCT01219829 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01219829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01219829 about?
NCT01219829 is a clinical study titled "Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma". The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.
What is the current status of trial NCT01219829?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2009-03-18. Estimated completion is 2021-04-27.
Who is sponsoring clinical trial NCT01219829?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI